The Canadian marijuana player reported better-than-expected Q1 financials for fiscal 2026, driven by an over 20% YoY increase ...

Canopy Growth (CGC) stock surges after its Q2 2026 earnings resolve going concern doubts amid strong cash balances and ...

Canopy Growth (CGC) delivered earnings and revenue surprises of +90.91% and -7.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial ...

Analysts estimate that Canopy Growth will report an earnings per share (EPS) of $-0.11. The announcement from Canopy Growth is eagerly anticipated, with investors seeking news of surpassing estimates ...

Reports Q2 revenue $83M, consensus $71.82M. “We’re building a stronger, more competitive company defined by continued momentum in Canada adult-use ...

Live Updates Live Coverage Has Ended Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get ...

The AdvisorShares Pure U.S. Cannabis ETF was up by 1.2% and the Amplify Alternative Harvest ETF gained 1.5%, the day after a positive election result for adult-use cannabis in Virginia. Among ...

While population growth across the metro looks different today than it did five years ago, one thing is clear: There’s a lot ...

Last week, Verano Holdings Corporation VRNO reported its third-quarter 2025 results. While earnings missed our estimates, ...

A research team has developed a cutting-edge deep learning framework, TM-WSNet, that dramatically improves the accuracy of ...

PEMGARDA® (pemivibart) net product revenue of $13.1 million reported for Q3 2025, representing 41% growth year-over-year and 11% growth ...